RBC Launches Coverage of GE HealthCare, Cites AI Pipeline and $22B Backlog as Growth Drivers
RBC Capital Markets began coverage of GE HealthCare Technologies with an Outperform rating and an $80 price target, highlighting the company’s ramped R&D since its 2023 separation from General Electric, a record $22 billion backlog, and a pipeline of AI-enabled imaging, diagnostics and software products that the firm says should accelerate revenue …